Revitt-A has a unique feature. Its components are structured down to nano sized particles and then surrounded with lipospheres sized 26 nm that protects them from the negative bioavailability factors described above, making them available for direct absorption to the cells.

The nanoparticles release the components in a sustained manner due to their hydrophilic shells, which “prevent enzymatic degradation of the cargo and protein adsorption onto the nanoparticles, This also prolongs blood circulation so that the cargo-loaded nanoparticles have enough time to accumulate in tumor tissues.

The extended circulation lifetime of ReVitt A is achieved by the use of these nano sized liposomes, delivering the curative payload of the liposomes is delivered directly to the cells, making ReVitt A very efficient.